What IDEX's Quarter ended Sep 30, 2026 10-Q says: 3 signals
IDEX filed its latest 10-Q with the SEC on Oct 28, 2026. It discusses capex increase, restructuring and restructuring charge.
Public (IEX)Machinery Manufacturing5,001 to 10,000 employeesidexcorp.comLinkedIn
Get IDEX's live signals in Claude or ChatGPT, or by API
What changed at IDEX this week? Use Autobound signals for idexcorp.com.- Filed
- Oct 28, 2026
- Period
- Quarter ended Sep 30, 2026
- Filings
- 3
- Signals
- 5
Source: Autobound Signal API · 60 signals tracked for IDEX · updated
10-Q · latest 5
What IDEX's 10-Q filings say
- SEC EDGAR
10-Q · Quarter ended Sep 30, 2026
Filed · 3 signals
IDEX plans closure of Health & Science Technologies facility alongside employee reductions
IDEX recorded restructuring expenses related to severance costs from employee reductions, including in connection with the anticipated closure of a facility in the HST segment.
Capital expenditures increased by $22.0 million to $65.9 million in nine months
Capital expenditures rose to $65.9 million for the nine months ended September 30, 2026, compared to $43.9 million in the prior year period.
$65.9M
capital expenditures in the first nine months of 2026
Restructuring expenses of $3.4 million incurred from severance and anticipated facility closure
The company recorded $3.4 million in restructuring expenses for the quarter, primarily relating to severance from employee reductions and the anticipated closure of a facility in the HST segment.
- SEC EDGAR
10-Q · Quarter ended Jun 30, 2026
Filed · 1 signal
Capital expenditures increased to $40.7 million in the first six months of 2026
Capital expenditures reached $40.7 million for the first six months of 2026 compared to $29.1 million in the prior year period.
$40.7M
capital expenditures in the first six months of 2026
- SEC EDGAR
10-Q · Quarter ended Mar 31, 2026
Filed · 1 signal
IDEX Incurred $7.4 Million in Restructuring Expenses and Asset Impairments in Q1 2026
The Company reported $7.4 million of restructuring expenses and asset impairments for the three months ended March 31, 2026, which included $4.8 million of asset impairments in FMT alongside severance costs from employee reductions.
Earnings calls
IDEX earnings headlines
From earnings call transcripts (Signal API type earnings-transcripts).
| Call date | What the company said |
|---|---|
| Organic sales rose 8%, adjusted EBITDA margin reached 27.8%Third-quarter results outperformed company guidance across organic sales, margins, and earnings. Organic sales grew 8% while adjusted EBITDA margin expanded 50 basis points to 27.8% and adjusted EPS rose 15% to $2.33. Strong cash flow generated $214 million with a 124% conversion rate. | |
| Full year 2026 organic sales growth guidance raised to 6.8%Full year 2026 organic growth outlook was raised to 6.5%-6.8% from prior 5%-6% guidance. Adjusted EPS guidance was boosted by $0.16 at the midpoint to $8.91-$8.96, and adjusted EBITDA margins were narrowed to 27.1%-27.3%. CapEx expectation was reiterated at approximately $110 million. | |
| Total orders rose 13% organically, approaching $1 billionConsolidated quarterly orders expanded 13% organically year over year to reach nearly $1 billion, keeping book-to-bill above 1.0x. Order growth was broad-based across all three reporting units, led by 21% growth in HST and 11% growth in FMT. | |
| Full year 2026 capital expenditures projected at approximately $110 millionCapital expenditure expectations were reaffirmed at approximately $110 million for full year 2026 to support ongoing platform growth. Free cash flow conversion is anticipated to track at or above 100% for the full year. | |
| Stubborn inflation and energy costs drive higher input expensesElevated energy prices and inflation continue to push input costs higher across manufacturing operations. The company is relying on targeted pricing actions, which contributed approximately 2% to top-line growth, alongside continuous improvement to offset these cost pressures. | |
| Persistent demand fatigue across chemical valves and agricultural end marketsThe Fluid & Metering Technologies segment continues to see year-over-year sales declines in chemical valves and agriculture. Management notes the chemicals sector remains especially fatigued due to sustained elevated input costs. |
Signal API · MCP
Track IDEX with the Signal API
One POST /v1/companies/enrich call with idexcorp.com returns IDEX 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"idexcorp.com","signal_types":["sec-10q"],"limit":20}'Bulk data
Need this signal for 10,000+ companies?
Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.
Same industry
10-Q at related companies
Questions about IDEX 10-Q
When did IDEX file its latest 10-Q?
What did IDEX disclose in its latest 10-Q?
What did IDEX say on its recent earnings calls?
Where can I read IDEX's 10-Q filing?
Page updated , the date of the newest row on this page.
Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .